TrialBridge

NCT05902156

Electronic Patient Decision Support System for Patients with Type 2 Diabetes (DiaPaDeSS)

Not Yet Recruiting · Not Applicable · Akdeniz University · registry updated 2025-02-06

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

This study evaluates the effects of an electronic patient decision support system developed for the use of patients with type 2 diabetes (DiaPaDeSS) on self-management, patient activation, and metabolic parameters. To manage type 2 diabetes after discharge, patients must continue to perform interventions at home, such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care. To achieve this, patient's self-management and activation levels should be increased. This can also lead to positive improvements in the metabolic parameters. It would be beneficial to develop DiaPaDeSS that can increase the self-management and activation levels of patients with type 2 diabetes. The investigators will develop the DiaPaDeSS intervention protocol. Our content includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. The content of the DiaPaDeSS will be evaluated by 10 experts in the fields of medicine, nursing, and informatics....

Inclusion

  • Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic
  • Aged between 18-65 years
  • Patients who know their diagnosis and can verbally express it
  • Have been diagnosed with type 2 diabetes for at least six months
  • Who are literate
  • Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools

Exclusion

  • Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months
  • Diagnosed with type 1 diabetes or gestational diabetes
  • Diagnosed with terminal illness
  • Using steroid therapy
  • Had pregnant
  • Having dementia and cognitive deficits

Open NCT05902156 on ClinicalTrials.govAll conditions